August has been a busy month as far as regulation goes. After coronary stents, the National Pharmaceutical Pricing Authority has issued an order that there will be...
The Indian healthcare industry is not able to cater to the vast population, and the situation shall not change drastically over the next five years. Attempts...
The Indian medical device industry continues its upward march of growth and is strongly supported by India’s robust legal framework. It will continue to reduce its...
Despite significant economic progress, India’s health indicators are nothing to boast of. With one of the highest infant-mortality rates in the world, 39 per 1000 live...
Buyers Guide is a journey undertaken by our team every year. It is a mammoth and thankless task to capture concisely the wide spectrum of products...
In a bid to assure Healthcare for All, the government seems to be in an aggressive, regulatory mood. The Medical Council of India recently reiterated its 2016 notification...
The National Health Policy 2017 has been approved by the Union Cabinet on March 15, 2017. Focusing on preventive healthcare, universal health coverage, and quality health...
The medical device sector is now to be included as one of the 25 priority sectors under the Make in India program. This would promote manufacturing and entrepreneurship,...
2017 promises to be an action-packed year for investors, notwithstanding the headwinds from the government’s recent demonetization move and weak global cues from Brexit and USA,...
Indian healthcare is a story of great contradictions – it has one of the lowest-cost healthcare systems in the world, yet it is unaffordable to the...
India has begun to bounce back in clinical trials with new regulations issued at frequent intervals. The latest guidance issued by the Ministry of Health &...
AMJ 2016 was the largest VC funding quarter for Healthcare IT companies since 2010, globally and for India. It climbed to USD 1.6 billion compared to...
The Indian healthcare industry is on the threshold of making its presence felt on the international map. The onus to realize this vision is on various...
Though medical and scientific advancements cannot be unwarranted, it will be the upcoming digital offerings that would change the dynamics of the industry. Clinically led improvement,...
India is emerging as a destination for quality healthcare services at affordable prices. It offers an attractive value proposition with multispecialty private healthcare services being provided...
Anju Arora is the founder and managing director of ADI Media Private Limited, a business-to-business (B2B) information provider. ADI Media’s B2B products include Medical Buyer, Communications Today, Broadcast & CableSat, and TV Veopar Journal.
She is an Economics Honors graduate from Lady Shri Ram College, New Delhi and PGDP from Indian Institute of Foreign Trade. She has also participated in the OPM Key Executives Program at Harvard Business School.
Anju Arora is also the co-founder and executive director on the Board of ADI BPO Services Limited, the majority shareholder in MPS Limited, listed on all the major India stock exchanges and a Macmillan company till 2011.
Copyright © 2025 Medical Buyer maintained by Fullstack development